Capricor Therapeutics (CAPR) Times Interest Earned (2013 - 2026)
Capricor Therapeutics (CAPR) posted quarterly Times Interest Earned of -$59.82 for Q1 2026, up 45.59% year-over-year from -$41.09 in Q1 2025, and up 49.22% quarter-over-quarter from -$117.82 in Q4 2025.
Capricor Therapeutics (CAPR) Times Interest Earned (2013 - 2026) Analysis & Trends
Capricor Therapeutics' Times Interest Earned history runs 14 years deep, the most recent figure standing at -$59.82 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 45.59% year-over-year to -$59.82; the TTM figure through Mar 2026 stood at -$290.8 (down 615.18% YoY), while the FY2025 annual figure was -$0.39, up 7.03% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$59.82, up from -$117.82 in the prior quarter.
- The five-year high for Times Interest Earned was $11.37 in Q4 2024, with the low at -$254.82 in Q1 2023.
- The 5-year median for Times Interest Earned is -$1.02 (2024), against an average of -$37.94.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned soared 429.9% in 2024, then slumped 33136.24% in 2025.
- Capricor Therapeutics' Times Interest Earned stood at -$17.13 in 2022, then jumped by 112.53% to $2.15 in 2023, then jumped by 429.9% to $11.37 in 2024, then plunged by 1136.27% to -$117.82 in 2025, then jumped by 49.22% to -$59.82 in 2026.
- Business Quant data shows CAPR's Times Interest Earned at -$59.82 in Q1 2026, -$117.82 in Q4 2025, and -$0.79 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Capricor Therapeutics | 383.47 Mn | 383.47 Mn | - | -59.82 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.82 |
| Dec 31, 2025 | -117.82 |
| Sep 30, 2025 | -0.79 |
| Jun 30, 2025 | -0.46 |
| Mar 31, 2025 | -109.96 |
| Dec 31, 2024 | 11.37 |
| Sep 30, 2024 | -0.11 |
| Jun 30, 2024 | -1.02 |
| Mar 31, 2024 | -0.33 |
| Dec 31, 2023 | 2.15 |
| Sep 30, 2023 | -1.86 |
| Jun 30, 2023 | -0.66 |
| Mar 31, 2023 | -254.82 |
| Dec 31, 2022 | -17.13 |
| Sep 30, 2022 | -0.36 |
| Jun 30, 2022 | -1.67 |
| Mar 31, 2022 | -91.76 |
| Dec 31, 2021 | 48.31 |
| Sep 30, 2021 | -0.75 |
| Sep 30, 2020 | -0.48 |